SAGE1: a potential target antigen for lung cancer T-cell immunotherapy. Li Y, Zhang Y, Yu X, Liu Q, et al. Mol Cancer Ther 2021 Aug 31. pii: 1535-7163.MCT-21-0203.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Zhang Y, Yu X, Liu Q, et al. SAGE1: a potential target antigen for lung cancer T-cell immunotherapy. Mol Cancer Ther 2021 Aug 31. pii: 1535-7163.MCT-21-0203.
PMID: 34465596